Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than US$1 billion in annual revenues.

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Wait Pausing Investments

Global 500, is an annual ranking of the top 500 corporations worldwide

Global 500
Revenue(RF), mln.USD
579
Staff
1069
Capital, mln.USD
365
Glob.Revenue, mln.USD
81288
Assets, mln.USD
384

In 2008, a legal entity Pfizer LLC was established and the first warehouse of the company's products in Russia was opened. There is no own production in Russia.

The Company Statement
March 14, 2022

Pfizer will donate all profits of the Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine. There will be no new clinical trials in Russia. Stopped new investments in Russia.

June 22, 2022Pfizer's Russian profit pledge bears fruit with $5M initial gift to Ukraine, CEO says
December 24, 2022Experts reported a decrease in the import of tranquilizers to Russia
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.